feed,title,long_url,short_url
SA,[itri] Itron targets $6.84–$6.94 EPS for 2025 as margin records set and Urbint acquisition advances,https://seekingalpha.com/news/4512046,
SA,[ew] Edwards Lifesciences raises 2025 guidance to high end of 9–10% sales growth and $2.56–$2.62 EPS amid strong Q3,https://seekingalpha.com/news/4512045,
